10 drugmakers expected to make the most money in the next 5 years

Roche is on track to be the highest-grossing drugmaker in the next five years, according to EvaluatePharma, a pharma-focused data analytics firm. 

EvaluatePharma recently forecasted the 10 drugmakers that may have the highest worldwide prescription drug sales by 2026. Here are their predictions:

1. Roche ($61 billion)
   
   
2. Johnson & Johnson ($56.1 billion)
   
   
3. Novartis ($54.8 billion)
   
   
4. Merck & Co. ($53.2 billion)
   
   
5. AbbVie ($52.7 billion)
   
   
6. Pfizer ($51.1 billion)
   
   
7. Bristol-Myers Squibb ($44.7 billion)
   
   
8. Sanofi ($41.7 billion)
   
   
9. AstraZeneca ($41 billion)
   
   
10. GlaxoSmithKline ($40.8 billion)